A Funders Collaborative
Initially launched by The Burke Foundation, the Community Health Acceleration Partnership, The Henry and Marilyn Taub Foundation, and the Robert Wood Johnson Foundation, with partnership and support from The Nicholson Foundation, the New Jersey Birth Equity Funders Alliance has come together to tackle birth inequities in support of Nurture New Jersey, a state-wide maternal and infant health strategic plan.
The Alliance members are deeply committed to leveraging our individual strengths and supporting communities and grassroots leaders to achieve birth equity.
Each organization goes about this differently while striving to be an authentic partner to communities and grassroots leaders.
The Burke Foundation invests in transformative maternal and child health and early childhood initiatives to build a cycle of opportunity across generations in New Jersey and beyond. Learn more.
With over 70 combined years of expertise and a deep network of partners in philanthropy, government affairs, policy-making, and grassroots advocacy, CHAP is leading efforts to recenter health in communities with a focus on birth equity and community health. Learn more.
The mission of the Robert Wood Johnson Foundation is to improve the health and wellbeing of everyone in America. This mission is inspired by their founder, General Robert Wood Johnson II. Carrying forward his legacy, the Foundation is dedicated to working toward a healthier nation rooted in equity, compassion, and respect. Learn more.
The Henry and Marilyn Taub Foundation makes grants to pre-selected organizations working in early childhood, aging in place, and medical research. A continuing focus of the Foundation is on local communities in New Jersey’s Bergen and Passaic counties, in areas with the greatest needs, including founder Henry Taub’s hometown of Paterson. Learn more.
Organon is a global healthcare company building a pipeline and portfolio of products focused on contraception, fertility, maternal and peripartum conditions, and conditions unique to or predominant in women. Learn more.
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Learn more.